Recent Finacing
Recent Raise
Affymax is a pharmaceutical company developing a once-monthly injectable anemia therapy aimed at reducing injection frequency as an alternative to existing injectable biologics and oral HIF‑PHI approaches.
Focus Areas
Total Raised
Funding round